Artal International S.C.A. 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-12 6:17 pm Sale |
2024-07-12 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal International S.C.A. | 116,155 4.300% |
-22,800 (-16.41%) |
Filing |
| 2024-02-09 5:06 pm Sale |
2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal International S.C.A. | 138,955 5.700% |
-1 (-0.00%) |
Filing |
| 2022-02-11 06:35 am Purchase |
2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal International S.C.A. | 138,956 6.400% |
48,077 (+52.90%) |
Filing |
| 2021-02-12 8:55 pm Sale |
2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal International S.C.A. | 90,879 5.400% |
-2,200 (-2.36%) |
Filing |